Long‑term scientific partnerships delivering decision confidence

Pharmidex builds strategic partnerships with organisations that share a commitment to scientific rigour, transparency, and meaningful progress in drug development. Our collaborations extend beyond individual studies, supporting programmes, portfolios, and research initiatives where quality, judgement, and delivery matter.

Our partners span biotechnology, pharmaceutical organisations, academic research groups, public–private consortia, and grant‑funded programmes, reflecting the breadth and credibility of our collaborative model.

Representative Partners & Collaborations

Industry & Biotech Partners

• Global biotech partner multi‑year collaboration delivering integrated pharmacology, bioanalysis, and toxicology to support IND‑enabling activities
• Specialist therapeutic biotech translational in vivo models and exposure–response analysis across multiple programmes
• Pharmaceutical partner GLP bioanalysis and safety support for regulated development studies

Academic & Grant‑Funded Collaborations

• UK academic consortium translational research support within a multi‑institution grant framework
• EU‑funded programme standardised in vivo execution and centralised bioanalysis across consortium partners
• Public–private partnership collaborative preclinical research aligned to funding milestones and reporting requirements

Types of Strategic Engagement

Pharmidex supports a range of partnership models, including:

• Collaborative research programmes  jointly defining study design and translational strategy
• Public–private partnerships  delivery within funded research frameworks
• Multi‑programme industry alliances  long‑term support across therapeutic portfolios
• Regulatory‑aligned development support  data generation for IND, CTA, and scientific advice

Each engagement is structured to reflect the scientific, regulatory, and commercial context of the programme.

Partner With Us

If you are exploring a strategic collaboration or seeking a preclinical partner who combines scientific judgement with integrated delivery, we would welcome a discussion.

➡️ Discuss partnership opportunities with our team

What Partnership Means at Pharmidex

A strategic partnership with Pharmidex is not a transactional supplier relationship. It is a collaborative engagement designed to reduce risk, improve data quality, and strengthen downstream decision‑making.

Our partners work with us because we provide:

• Senior scientific involvement from study conception through interpretation
• Integrated capability across in vivo, bioanalysis, formulation, and translational science
• Flexible engagement models aligned to programme maturity and funding structure
• Regulatory awareness embedded into study design and reporting

This approach allows our partners to progress complex programmes with confidence and continuity.

Case Studies in Collaboration

Biotech Partner — Integrated Preclinical Support

Pharmidex supported a venture‑backed biotech from lead optimisation through

IND‑enabling studies by providing:

• Mechanistic in vivo pharmacology to support candidate selection
• GLP bioanalysis generating regulator‑ready PK and TK data
• Integrated reporting aligned with regulatory submission strategy

The partnership enabled confident progression into formal development with reduced programme risk.

Academic Consortium — Translational Research Network 

Within a multi‑institution research collaboration, Pharmidex delivered:

• Harmonised in vivo protocols across partner sites
• Centralised bioanalysis and data quality oversight
• Consistent reporting aligned with grant and milestone requirements

This approach ensured data integrity and comparability across the consortium.



What Our Partners Value 

Our long‑standing partnerships are built on:

• Consistent scientific standards
• Transparent communication and governance
• Willingness to challenge assumptions constructively
• Reliable delivery under time and regulatory pressure

These principles underpin the trust our partners place in us.